Your browser does not support JavaScript! BISMUSAL (BISMUTH SUBSALICYLATE) SUSPENSION [DURVET, INC.]

Veterinary Medicine Labels  

                Current Medication Information

Options

RxNorm Names

BISMUSAL (bismuth subsalicylate) suspension
[Durvet, Inc.]


Category DEA Schedule Marketing Status
OTC ANIMAL DRUG LABEL unapproved drug other
NOTE:THIS DRUG HAS NOT BEEN FOUND BY FDA TO BE SAFE AND EFFECTIVE, AND THIS LABELING HAS NOT BEEN APPROVED BY FDA. For further information about unapproved drugs, click here.
Drug Label Sections

INDICATIONS

A palatable oral suspension for use as an aid in the control of simple diarrhea in cattle, horses and dogs.

CONTRAINDICATIONS

Not recommended for use in cats.

CAUTION

This product contains salicylate; do not administer with other salicylate-containing products, such as aspirin.

DOSAGE AND ADMINISTRATION

Administer orally after the first sign of diarrhea and after each loose bowel movement or as needed.

Dogs--1 to 3 tablespoonfuls
Calves-- 3 to 4 ounces
Foals-- 3 to 4 ounces
Cattle and Horses-- 6-10 fl. ozs.

This product may cause stools to darken. If diarrhea persists after using this product for 2 days, contact a veterinarian.

COMPOSITION

Bismuth Subsalicylate .................. 1.75%
in a palatable aqueous suspension.
Flavoring and coloring added.

FOR ORAL USE ONLY


SHAKE WELL BEFORE USING

Store at room temperature not above 37oC (98.6oF).

Protect from freezing.

TAKE TIME OBSERVE LABEL DIRECTIONS

NDC 30798-334-35

FOR ANIMAL USE ONLY

KEEP OUT OF REACH OF CHILDREN

NET CONTENTS: 1 GALLON (3.785 L)

Manufactured for:
DURVET, INC.
Blue Springs, Missouri 64014

Iss. 2-02

DV-Bismusal Suspension Label
BISMUSAL 
bismuth subsalicylate suspension
Product Information
Product TypeOTC ANIMAL DRUG LABELItem Code (Source)NDC:30798-334
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (BISMUTH CATION) BISMUTH SUBSALICYLATE66.2 mg  in 3.785 L
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:30798-334-353.785 L in 1 JUG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/21/2002
Labeler - Durvet, Inc. (056387798)

Revised: 2/2013
 
Durvet, Inc.

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services